Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors
Article in Biochemical Pharmacology (August 2023)
The most recent citing publications are shown below. View all 26 publications that cite this research output on Dimensions.
Article in Biochemical Pharmacology (August 2023)
Article in International Journal of Hematology-Oncology and Stem Cell Research (July 2022)
Article in Cancer Biology & Therapy (April 2021)